Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy

Journal of Molecular Histology

Volumn 38, Issue 1, 2007, Pages 1-11

  Karaivanov, M ^a   Todorova, K ^b   Kuzmanov, A ^b   Hayrabedyan, S ^b  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Basal cells; COX 2; GST; p63; Proliferative inflammatory atrophy; Prostate intraepithelial neoplasia; Quantitative immunohistochemistry

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CYCLOOXYGENASE 2; GLUTATHIONE TRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PARAFFIN; PROTEIN P63;

ADULT; AGED; ARTICLE; ATROPHY; BASAL CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROGENY; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SECRETORY CELL; TISSUE SECTION;

AGED; AGED, 80 AND OVER; ATROPHY; CELL PROLIFERATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33947257415     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-006-9070-5     Document Type: Article

References (32)

1. Aaltoma SH, Lipponen PK, Kosma VM (2001) Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res 21:3101-3106
2. Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T, Fujioka T, Shuin T, Nakamura Y (2004) Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 64:5963-5972
3. Baltaci S, Orhan D, Gogus C, Turkolmez K, Tulunay O, Gogus O (2001) Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma. BJU Int 88:100-103
4. Banerjee AG, Liu J, Yuan Y, Gopalakrishnan VK, Johansson SL, Dinda AK, Gupta NP, Trevino L, Vishwanatha JK (2003) Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA. Mol Cancer 2:34
5. Chang YW, Jakobi R, Mcginty A, Foschi M, Dunn MJ, Sorokin A (2000) Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol 20:8571-8579
6. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155:1985-1992
7. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG (2003) Human prostate cancer precursors and pathobiology. Urology 62:55-62
8. Hayrabedyan S, Kyurkchiev S, Kehayov I (2006) Evaluation of IL-1A expression in endometriotic lesions using quantitative immunohistochemistry approach. Proc Bulg Acad Sci 59:229
9. Hussain T, Gupta S, Mukhtar H (2003) Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 191:125-135
10. Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG (2003) Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol 34:792-796
11. Jiang Z, Li C, Fischer A, Dresser K, Woda BA (2005) Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol 123:231-236
12. Kirschenbaum A, Klausner AP, Lee R, Unger P, Yao S, Liu XH, Levine AC (2000) Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 56:671-676
13. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K (1998) Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82:1897-1903
14. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM (2002) Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 62:2220-2226
15. Matkowskyj KA, Cox R, Jensen RT, Benya RV (2003) Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J Histochem Cytochem 51:205-214
16. Matkowskyj KA, Schonfeld D, Benya RV (2000) Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab. J Histochem Cytochem 48:303-312
17. Montironi R, Mazzucchelli R, Algaba F, Lopez-Beltran A (2000a) Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol 53(9):655-665
18. Montironi R, Mazzucchelli R, Stramazzotti D, Pomante R, Thompson D, Bartels PH (2000b) Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. Mol Pathol 53:122-128
19. Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G (2002) Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. PNAS 99:12483-12488
20. Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, De Marzo AM (2003) Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163:923-933
21. Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG (2004) GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem 91:540-552
22. Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW (2001) Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann N Y Acad Sci 952:135-144
23. Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, Nelson WG (2005) Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26:1170-1181
24. Parsons JK, Nelson CP, Gage WR, Nelson WG, Kensler TW, De Marzo AM (2001) GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue. Prostate 49:30-37
25. Srigley JR (2004) Benign mimickers of prostatic adenocarcinoma. Mod Pathol 17:328-348
26. Sugar LM (2006) Inflammation and prostate cancer. Can J Urol 13(Suppl 1):46-47
27. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99:6567-6572
28. Wang J, Torbenson M, Wang Q, Ro JY, Becich M, Aaltoma SH, Lipponen PK, Kosma VM, Baltaci S, Orhan D, Gogus C, Turkolmez K, Tulunay O, Gogus O, Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K (2003) Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Urol Oncol 21:117-122
29. Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, Yoshimura N, Hla T, Wada S (2000) Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89:589-596
30. Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM, Isaacs WB (2003) Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 63:7365-7376
31. Zha S, Gage WR, Sauvageot J, Saria EA, Putzi MJ, Ewing CM, Faith DA, Nelson WG, De Marzo AM, Isaacs WB (2001) Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res 61:8617-8623
32. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA (2002) Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 26:926-931